Rapamycin Target Eluting Coronary Stent System
Firehawk® as the first and only Target Eluting Stent (TES), features over 600 groves on the stent strut surface, and a target release technology that allows for 1/3 of the dosage versus conventional stents.
The result is a unique solution that combines the strength of both drug eluting stents and bare metal stents.
With the continuous increase in the body of clinical evidence to demonstrate its ‘golden standard’ in safety and efficacy, Firehawk® is establishing its status as an elite workhorse drug-eluting stent for clinics across the globe.
Learn more at https://www.microport.com/en/healthcare-professional/cardiovascular/percutaneous-coronary-intervention
There are no reviews yet.